# Shanghai Shengpu Zetai Pharmaceutical Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shanghai-shengpu-zetai-pharmaceutical-technology-co

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Total disclosed funding: $16M
- Latest round: Series A (Apr 2, 2022)
- Investors on record: 2

## About

Based in Shanghai, China, and founded in 2019, Shanghai Shengpu Zetai Pharmaceutical Technology Co., Ltd is a biotech company providing an AI-CRDMO service platform from new drug discovery to industrial production.

The company provides pharmaceutical companies with AI design and synthesis preparation of drug molecules, preclinical animal experiment validation, delivery of preclinical candidate compounds (PCCs), clinical filing of innovative drugs, and supply of API production.

## Funding rounds

- Series A, Apr 2, 2022, $16M — Cowin Capital, Shanghai Zhaoqian Assets Management

## Investors

- Cowin Capital (https://capitalatlas.ai/funds/cowin-capital) — Series A
- Shanghai Zhaoqian Assets Management (https://capitalatlas.ai/funds/shanghai-zhaoqian-assets-management) — Series A